CS logo
small CS logo
Praxis Fuer Haematologie Internistische Onkologie

Cologne, Germany

About Praxis Fuer Haematologie Internistische Onkologie


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Praxis Fuer Haematologie Internistische Onkologie


During the past decade, Praxis Fuer Haematologie Internistische Onkologie conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Two Chemotherapy Regimens Compared With Observation in Treating Patients With Completely Resected Pancreatic Cancer
2001-07-01
2010-09-01
Completed
1,030
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Adjuvant Chemotherapy in Treating Women Who Have Undergone Resection for Relapsed Breast Cancer; Chemotherapy as Adjuvant for LOcally Recurrent Breast Cancer
2002-07-01
2016-08-22
Completed
162
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)
2004-04-01
2007-05-01
Completed
5,745

Rows per page:

1–100 of 272

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Praxis Fuer Haematologie Internistische Onkologie" #1 sponsor was "German CLL Study Group" with 4 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 4 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "III. Medizinische Klinik Mannheim" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Praxis Fuer Haematologie Internistische Onkologie" #1 collaborator was "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Praxis Fuer Haematologie Internistische Onkologie


According to Clinical.Site data, the most researched conditions in "Praxis Fuer Haematologie Internistische Onkologie" are "Chronic Lymphocytic Leukemia" (4 trials), "Lymphoma" (4 trials), "Leukemia" (2 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Praxis Fuer Haematologie Internistische Onkologie" in a lesser frequency.

Clinical Trials Intervention Types at Praxis Fuer Haematologie Internistische Onkologie


Most popular intervention types in "Praxis Fuer Haematologie Internistische Onkologie" are "Drug" (11 trials), "Biological" (7 trials), "Radiation" (4 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (6 trials), "doxorubicin hydrochloride" (5 trials), "prednisone" (4 trials), "radiation therapy" (4 trials) and "rituximab" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Praxis Fuer Haematologie Internistische Onkologie


The vast majority of trials in "Praxis Fuer Haematologie Internistische Onkologie" are 10 trials for "All" genders and 1 trials for "Female" genders.

Clinical Trials Status at Praxis Fuer Haematologie Internistische Onkologie


Currently, there are NaN active trials in "Praxis Fuer Haematologie Internistische Onkologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Praxis Fuer Haematologie Internistische Onkologie, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Praxis Fuer Haematologie Internistische Onkologie, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status